{
    "root": "74fca797-ddb1-4cac-9cf1-4ea702d1d6a8",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "EVRYSDI",
    "value": "20250318",
    "ingredients": [
        {
            "name": "RISDIPLAM",
            "code": "76RS4S2ET1"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A"
        },
        {
            "name": "ISOMALT",
            "code": "S870P55O2W"
        },
        {
            "name": "MALTODEXTRIN",
            "code": "7CVR7L4A2D"
        },
        {
            "name": "TARTARIC ACID",
            "code": "W4888I119H"
        },
        {
            "name": "SODIUM BENZOATE",
            "code": "OJ245FE5EU"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "SUCRALOSE",
            "code": "96K6UQ3ZD4"
        },
        {
            "name": "ASCORBIC ACID",
            "code": "PQ6CK8PD0R"
        },
        {
            "name": "EDETATE DISODIUM",
            "code": "7FLD91C86K"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "CROSPOVIDONE, UNSPECIFIED",
            "code": "2S7830E561"
        },
        {
            "name": "SODIUM STEARYL FUMARATE",
            "code": "7CV7WJK4UI"
        },
        {
            "name": "POLYVINYL ALCOHOL, UNSPECIFIED",
            "code": "532B59J990"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        }
    ],
    "indications": "evrysdi indicated treatment spinal muscular atrophy ( sma ) pediatric adult patients .",
    "contraindications": "administer daily without food per table ( 2.1 ) : age body weight recommended daily form less 2 months age 0.15 mg/kg evrysdi oral solution 2 months less 2 years age 0.2 mg/kg 2 years age older weighing less 20 kg 0.25 mg/kg 2 years age older weighing 20 kg 5 mg evrysdi oral solution evrysdi tablet swallow evrysdi tablet whole water dispersed non-chlorinated drinking water ( e.g . , filtered water ) . ( 2.2 ) administer evrysdi oral solution provided oral syringe . ( 2.2 ) evrysdi oral solution must constituted healthcare provider prior dispensing . ( 2.4 ) full prescribing information important preparation instructions . ( 2.2 , 2.4 )",
    "warningsAndPrecautions": null,
    "adverseReactions": "none .",
    "indications_original": "EVRYSDI is indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients.",
    "contraindications_original": "Administer once daily with or without food per the table below ( 2.1 ): Age and Body Weight Recommended Daily Dosage Dosage Form Less than 2 months of age 0.15 mg/kg EVRYSDI for Oral Solution 2 months to less than 2 years of age 0.2 mg/kg 2 years of age and older weighing less than 20 kg 0.25 mg/kg 2 years of age and older weighing 20 kg or more 5 mg EVRYSDI for Oral Solution or EVRYSDI Tablet Swallow EVRYSDI tablet whole with water or dispersed in non-chlorinated drinking water (e.g., filtered water). ( 2.2 ) Administer EVRYSDI for oral solution with the provided oral syringe. ( 2.2 ) EVRYSDI for oral solution must be constituted by a healthcare provider prior to dispensing. ( 2.4 ) See Full Prescribing Information for important preparation and administration instructions. ( 2.2 , 2.4 )",
    "adverseReactions_original": "None."
}